(0.02%) 5 101.13 points
(0.20%) 38 315 points
(0.04%) 15 934 points
(-1.30%) $82.76
(6.24%) $2.04
(0.07%) $2 348.80
(-0.23%) $27.47
(3.79%) $957.05
(-0.20%) $0.933
(-0.29%) $10.99
(-0.53%) $0.796
(1.67%) $93.41
Live Chart Being Loaded With Signals
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions...
Stats | |
---|---|
Dagens volum | 976 585 |
Gjennomsnittsvolum | 779 209 |
Markedsverdi | 17.15B |
EPS | $0 ( 2024-04-25 ) |
Neste inntjeningsdato | ( $3.82 ) 2024-07-25 |
Last Dividend | $0.720 ( 2023-11-07 ) |
Next Dividend | $0 ( N/A ) |
P/E | 44.15 |
ATR14 | $0.169 (0.08%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-15 | Eisenberg Glenn A | Buy | 10 229 | Common Stock |
2024-04-15 | Eisenberg Glenn A | Sell | 4 496 | Common Stock |
2024-04-15 | Eisenberg Glenn A | Sell | 10 229 | Restricted Stock Unit |
2024-04-01 | Schroeder Mark S | Sell | 6 477 | Common Stock |
2024-04-01 | Summy Amy B. | Sell | 3 500 | Common Stock |
INSIDER POWER |
---|
-9.86 |
Last 100 transactions |
Buy: 251 595 | Sell: 302 098 |
Volum Korrelasjon
Laboratory Corporation of Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Laboratory Corporation of Korrelasjon - Valuta/Råvare
Laboratory Corporation of Økonomi
Annual | 2023 |
Omsetning: | $12.16B |
Bruttogevinst: | $3.15B (25.86 %) |
EPS: | $4.80 |
FY | 2023 |
Omsetning: | $12.16B |
Bruttogevinst: | $3.15B (25.86 %) |
EPS: | $4.80 |
FY | 2022 |
Omsetning: | $14.88B |
Bruttogevinst: | $4.39B (29.48 %) |
EPS: | $14.04 |
FY | 2021 |
Omsetning: | $16.12B |
Bruttogevinst: | $5.62B (34.89 %) |
EPS: | $24.60 |
Financial Reports:
No articles found.
Laboratory Corporation of Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.720 (N/A) |
$0.720 (N/A) |
$0.720 (N/A) |
$0.720 (N/A) |
$0.720 (N/A) |
$0.720 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.150 | 1990-12-31 |
Last Dividend | $0.720 | 2023-11-07 |
Next Dividend | $0 | N/A |
Payout Date | 2023-12-12 | |
Next Payout Date | N/A | |
# dividends | 21 | -- |
Total Paid Out | $7.64 | -- |
Avg. Dividend % Per Year | 0.54% | -- |
Score | 2.7 | -- |
Div. Sustainability Score | 8.69 | |
Div.Growth Potential Score | 5.16 | |
Div. Directional Score | 6.92 | -- |
Year | Amount | Yield |
---|---|---|
1990 | $0.150 | 0.61% |
1991 | $0.500 | 2.19% |
1992 | $0.950 | 1.59% |
1993 | $0.800 | 2.11% |
1994 | $0.200 | 0.65% |
1995 | $0 | 0.00% |
1996 | $0 | 0.00% |
1997 | $0 | 0.00% |
1998 | $0 | 0.00% |
1999 | $0 | 0.00% |
2000 | $0 | 0.00% |
2001 | $0 | 0.00% |
2002 | $0 | 0.00% |
2003 | $0 | 0.00% |
2004 | $0 | 0.00% |
2005 | $0 | 0.00% |
2006 | $0 | 0.00% |
2007 | $0 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $2.16 | 0.84% |
2023 | $2.88 | 1.41% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0352 | 1.500 | 9.30 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0262 | 1.200 | 9.13 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0533 | 1.500 | -0.518 | -0.778 | [0.1 - 1] |
payoutRatioTTM | 0.581 | -1.000 | 4.19 | -4.19 | [0 - 1] |
currentRatioTTM | 0.877 | 0.800 | -0.615 | -0.492 | [1 - 3] |
quickRatioTTM | 0.584 | 0.800 | -1.268 | -1.015 | [0.8 - 2.5] |
cashRatioTTM | 0.0252 | 1.500 | -0.971 | -1.457 | [0.2 - 2] |
debtRatioTTM | 0.319 | -1.500 | 4.69 | -7.03 | [0 - 0.6] |
interestCoverageTTM | 10.56 | 1.000 | 7.20 | 7.20 | [3 - 30] |
operatingCashFlowPerShareTTM | 13.99 | 2.00 | 5.34 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 7.95 | 2.00 | 6.03 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.662 | -1.500 | 7.35 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.268 | 1.000 | 8.87 | 8.87 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0875 | 1.000 | -0.249 | -0.249 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.223 | 1.000 | 9.87 | 9.87 | [0.2 - 2] |
assetTurnoverTTM | 0.744 | 0.800 | 8.37 | 6.70 | [0.5 - 2] |
Total Score | 8.69 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 38.53 | 1.000 | 6.21 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0533 | 2.50 | -0.333 | -0.778 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 7.95 | 2.00 | 7.35 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.452 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 13.99 | 2.00 | 5.34 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.581 | 1.500 | 4.19 | -4.19 | [0 - 1] |
pegRatioTTM | 2.23 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0957 | 1.000 | -0.108 | 0 | [0.1 - 0.5] |
Total Score | 5.16 |
Laboratory Corporation of
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.